Skip to main content
. 2024 Jul 25;42(19):3989–3998. doi: 10.1016/j.vaccine.2024.05.009

Fig. 2.

Fig. 2

Geometric mean IgG titers (with 95% CI) against ancestor SARS-CoV-2 on Days 0, 28 and 84 after a booster vaccination with protein SCB-2019, adenovirus-vector ChAdOx1-S or mRNA BNT162b2 COVID-19 vaccines according to previous booster history (PPS excluding cases of COVID-19 during the study).